Impax Labs TCPA Fax Advertisements Class Action Settlement
All individuals and/or entities whom or which received one or more unsolicited advertisements via facsimile from Defendant between December 1, 2013 and September 29, 2017.
Your share of the Distributable Settlement Fund depends on how many Settlement Class Members submit Claim Forms and how many allegedly violative faxes (in the aggregate) they claim to have received.
Proof of Purchase
Family Medicine Pharmacy LLC v. Impax Laboratories Inc., Case No. 1:17-cv-00053
District Court for the Southern District of Alabama
Plaintiff Family Medicine Pharmacy LLC (“Plaintiff”) sued Impax, alleging that it received unsolicited facsimile advertisements sent by the Defendant promoting Defendant’s goods and/or services, without prior consent or an established business relationship, in violation of the Telephone Consumer Protection Act (“TCPA”), 47 U.S.C. & 227. Plaintiff sought to represent a class of persons to whom Defendant sent the allegedly unsolicited facsimile advertisements. Defendant denies these allegations but has agreed to settle these claims solely to avoid the costs and uncertainties of litigation. Defendant will vigorously defend the lawsuit if the proposed settlement is not approved. Plaintiff has brought this action on behalf of itself and the Settlement Class.
FMP v. Impax Laboratories Settlement Administrator
c/o JND Class Action Administration
PO Box 6998
Broomfield, CO 80021